NextCure (NXTC) executive compensation, 2026 proxy

Michael Richman, President and Chief Executive Officer, was paid $941,692 in 2025, down 38% from $1.5M the year before.

Filed
April 24, 2026
Annual meeting
June 18, 2026
Pay year
2025
Named executives
3
CEO total pay
$941,692-38% vs prior year
CEO Base Salary
$609,2582025 annual base salary
CEO Option Awards
$189,170Grant date fair value
Incentive Payout
40%Of target based on goals

How Richman was paid

$941,692 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary65%Option awards20%Non-equity incentive13%All other compensation2%

Named executive officers

ExecutiveTotal
Michael RichmanPresident and Chief Executive Officer$941,692
Udayan Guha, M.D., Ph.D.Chief Medical Officer$639,239
Timothy Mayer, Ph.D.Chief Operating Officer$633,181

What changed and why

  • $1.5MCEO total compensation decreased from $1,510,939 in 2024 to $941,692 in 2025.
  • 40%Corporate performance goals achieved 40% of target payout for annual cash incentives.
  • Option awards were granted in January 2025 reflecting long-term performance incentives.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.